Co says data presented at the 43rd Annual Meeting of the European Association for the Study of Diabetes demonstrated that, when used investigationally as initial therapy in combination with metformin, ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. AMLN will be presenting at the Piper Jaffray Europe Conference in London on Wednesday, June 24, 2009 at 10:30 a.m ...

JANUVIA (sitagliptin), Merck's once-a-day oral treatment for patients with type 2 diabetes, has been granted a license from the European Commission. JANUVIA now becomes the first and only medication ...